CEO going to be presenting to institutional investors in NYChttps://www.newcannabisventures.com/leading-cannabis-companies-to-present-to-nyc-institutional-investors/
Anyone know much about the Cowen Group? One of their divisions runs a $10 bilion fund.
In the afternoon, Mark Whitmore of Deloitte Private will discuss the market opportunity in Canada. The CEOs of three Canadian licensed producers will follow, with Bruce Linton of Canopy Growth (TSX: CGC) (OTC: TWMJF), Denis Arsenault of OrganiGram (TSXV: OGI) (OTC: OGRMF) and Michael Gorenstein of The Cronos Group (TSXV: MJN) (OTC: PRMCF), previously PharmaCan Capital, participating in a panel discussion. In November, Canopy Growth engaged Cowen and Company for investment banking services.
The last panel, which addresses technology, includes Mark Grindeland of Coda Signature, Lynn Hodderd of Mary’s Medicinals and Tyler Goldman, the new CEO at PAX Labs. The event is by invitation-only for clients and guests of Cowen and Company.